ROSANNA CATALASAN

Allopathic & Osteopathic Physicians|Family Medicine MIDLAND, TX NPI 1487837712

General Payments — all program years on this page

$3,165.12

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 172
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $406.22 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $406.2220

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $538.8029
2019 $440.4426
2020 $310.2517
2021 $651.1433
2022 $362.8822
2023 $455.3925
2024 $406.2220

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1097005372 Novo Nordisk Inc $18.13 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097703474 Novo Nordisk Inc $24.96 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097734436 Novo Nordisk Inc $25.50 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104223619 AstraZeneca Pharmaceuticals LP $13.94 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104267225 AstraZeneca Pharmaceuticals LP $21.15 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104535217 AstraZeneca Pharmaceuticals LP $19.97 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104572964 AstraZeneca Pharmaceuticals LP $20.99 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105494423 AstraZeneca Pharmaceuticals LP $15.51 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105631837 AstraZeneca Pharmaceuticals LP $22.37 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105719496 AstraZeneca Pharmaceuticals LP $20.09 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105766944 AstraZeneca Pharmaceuticals LP $25.52 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115485472 Amgen Inc. $25.88 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125091502 Abbott Laboratories $17.79 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135339474 Lilly USA, LLC $21.39 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135358860 Lilly USA, LLC $25.24 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135392057 Lilly USA, LLC $17.35 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135403706 Lilly USA, LLC $15.85 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135405320 Lilly USA, LLC $22.33 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135405322 Lilly USA, LLC $13.31 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153470631 Salix Pharmaceuticals, a division of Bausch Health US, LLC $18.95 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.